Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. (Q30386485)

12 September 2017

2 references

11 December 2020

20 October 2022

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. (English)

1 reference

12 September 2017

1 reference

7 November 2019

1 reference

16 September 2019

1 reference

27 October 2020

1 reference

11 December 2020

1 reference

PubMed publication ID

1

Regina Dutkowski

1 reference

PMC publication ID

2835508

12 September 2017

language of work or name

English

0 references

publication date

1 April 2010

12 references

Journal of Antimicrobial Chemotherapy

12 September 2017

13 March 2019

23 March 2019

22 June 2019

20 June 2019

25 June 2019

16 September 2019

7 November 2019

1 July 2020

27 October 2020

11 December 2020

20 October 2022

12 references

12 September 2017

13 March 2019

23 March 2019

22 June 2019

20 June 2019

25 June 2019

16 September 2019

7 November 2019

1 July 2020

27 October 2020

11 December 2020

20 October 2022

65 Suppl 2

1 reference

12 September 2017

ii11-ii24

1 reference

Creative Commons Attribution-NonCommercial

12 September 2017

11 references

13 March 2019

23 March 2019

22 June 2019

20 June 2019

25 June 2019

16 September 2019

7 November 2019

1 July 2020

27 October 2020

11 December 2020

20 October 2022

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Reducing the burden of influenza-associated complications with antiviral therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

The influence of oseltamivir treatment on the risk of stroke after influenza infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Influenza-associated central nervous system dysfunction: a literature review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Influenza virus susceptibility and resistance to oseltamivir.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Use of Oseltamivir to control influenza complications after bone marrow transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Safety and pharmacology of oseltamivir in clinical use.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Mortality associated with influenza and respiratory syncytial virus in the United States

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Early administration of oral oseltamivir increases the benefits of influenza treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Treatment of influenza with neuraminidase inhibitors: virological implications

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Oral oseltamivir treatment of influenza in children.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

The impact of influenza epidemics on hospitalizations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

20 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Effects of oseltamivir on influenza-related complications in children with chronic medical conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Fatal oseltamivir-resistant influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza-associated central nervous system dysfunction in Taiwanese children: clinical characteristics and outcomes with and without administration of oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza-Associated Deaths among Children in the United States, 2003–2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Assessing the burden of influenza and other respiratory infections in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ012

Influenza vaccination coverage among children aged 6-59 months--eight immunization information system sentinel sites, United States, 2007-08 influenza season

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Clinical benefits with oseltamivir in treating influenza in adult populations : results of a pooled and subgroup analysis.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Influenza in Singapore: assessing the burden of illness in the community.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835508

Low coverage of seasonal influenza vaccination in the elderly in many European countries

26 November 2018

1 reference

12 December 2020

Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children

1 reference

12 December 2020

Oseltamivir phosphate in infants under 1 year of age with influenza infection

1 reference

12 December 2020

Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study

1 reference

12 December 2020

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

1 reference

12 December 2020

Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons

1 reference

12 December 2020

Identifiers

DOI

10.1093/JAC/DKQ012

1 reference

12 September 2017

1 reference

PMC publication ID

2835508

12 September 2017

PubMed publication ID

20215131

1 reference

PMC publication ID

2835508